RecruitingNot ApplicableNCT05800002

IVUS-guided DES Implantation in Coronary Calcification

Intravascular Ultrasound Versus Angiography Guided Drug-eluting Stent Implantation for Patients With Coronary Severe Calcification: a Prospective, Multicenter, Randomized Controlled Trial


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

864 participants

Start Date

Apr 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Coronary calcified lesion is associated with a poor clinical outcome. Intravascular ultrasound (IVUS) provides anatomic information in detail about reference vessel dimensions and lesion characteristics including severity of diameter stenosis, lesion length, and morphology. Both randomized and observational studies have reported the clinical benefits of IVUS guidance for patients with chronic total occlusion (CTO), long lesions, acute coronary syndrome (ACS) with complex bifurcation lesions. Our previous ULTIMATE trial has demonstrated that IVUS-guided drug-eluting stent (DES) implantation significantly improved clinical outcome in all-comers, particularly for patients who had an IVUS-defined optimal procedure, compared with angiography guidance. However, the benefit of IVUS guidance in coronary severe calcification still remains unknown in the modern DES era.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Silent ischemia, stable or unstable angina, non-ST-segment elevation myocardial infarction > 48 hours, or ST-segment elevation myocardial infarction > 7 days;
  • De novo coronary lesion eligible for drug-eluting stent implantation;
  • Target lesion with severe calcification;

Exclusion Criteria10

  • Age less than 18-year-old;
  • Comorbidity with a life expectancy <12 months;
  • Intolerant of antithrombotic therapy;
  • Significant anemia, thrombocytopenia, or leucopenia;
  • History of major hemorrhage (intracranial, gastrointestinal, and so on);
  • Chronic total occlusion lesion not recanalized;
  • Scheduled major surgery in the next 12 months;
  • Left ventricular ejection fraction < 25%;
  • Uremia dependent on dialysis treatment;
  • Previous drug-eluting stent implantation in target vessel;

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREIntravascular ultrasound

Pretreatment strategy, stent size, stent landing zone and post-dilation balloon size are depended on intravascular ultrasound.

PROCEDUREAngiography

Pretreatment strategy, stent size, stent landing zone and post-dilation balloon size are depended on angiography.


Locations(1)

Nanjing First Hospital

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05800002


Related Trials